Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Nov 6, 2026, 4:00 PM EST
1.394
+0.014 (1.04%)
After-hours: Nov 6, 2026, 7:30 PM EST
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Pulmatrix the 43,647th largest employer in the world and 7,242nd in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,014,500
Market Cap
5.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -20 | -90.91% | 2 | 0 |
| Dec 31, 2023 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2022 | 29 | 4 | 16.00% | 28 | 1 |
| Dec 31, 2021 | 25 | 3 | 13.64% | 24 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Senti Biosciences Holdings | 39 |
| Cerenome | 28 |
| AIM ImmunoTech | 21 |
| Imunon | 20 |
| Cardio Diagnostics Holdings | 17 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
PULM News
- 9 days ago - Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study - GlobeNewsWire
- 13 days ago - Pulmatrix Transcript: EGM 2026 - Transcripts
- 17 days ago - Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse - GlobeNewsWire
- 4 weeks ago - Pulmatrix Proxy statement: Proxy filing - Filings
- 4 weeks ago - Pulmatrix Registration statement: Registration filing - Filings
- 6 weeks ago - Pulmatrix Proxy statement: Proxy filing - Filings
- 6 weeks ago - Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria - GlobeNewsWire
- 2 months ago - Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - PRNewsWire